AAAAAA
Results: 1-25/67
Authors:
BEHR TM
WORMANN B
GRATZ S
HOLLER E
KOLB HJ
HIDDEMANN W
GOLDENBERG DM
BECKER W
Citation: Tm. Behr et al., 36TH INTERNATIONAL ANNUAL-MEETING OF THE GERMAN-SOCIETY-FOR-NUCLEAR-MEDICINE, Nuklearmedizin, 37(2), 1998, pp. 4-101
Authors:
BEHR TM
SPES CH
PONGRATZ DE
WEISS M
MEISER B
UBERFUHR P
THEISEN K
ANGERMANN CE
Citation: Tm. Behr et al., ADULT HUMAN CARDIOMYOCYTES COEXPRESS VIMENTIN AND KI67 IN HEART-TRANSPLANT REJECTION AND IN DILATED CARDIOMYOPATHY, The Journal of heart and lung transplantation, 17(8), 1998, pp. 795-800
Authors:
SPES CH
KLAUSS V
SCHNAACK SD
TAMMEN AR
HENNEKE KH
RIEBER J
BEHR TM
UBERFUHR P
REICHART B
THEISEN K
ANGERMANN CE
MUDRA H
Citation: Ch. Spes et al., SAFETY OF MONITORING HEART-TRANSPLANT RECIPIENTS WITHOUT ANNUAL ROUTINE CORONARY ANGIOGRAPHY, Journal of the American College of Cardiology, 31(2), 1998, pp. 207-207
Authors:
REDDY N
ONG GL
BEHR TM
SHARKEY RM
GOLDENBERG DM
MATTES MJ
Citation: N. Reddy et al., RAPID BLOOD CLEARANCE OF MOUSE IGG2A AND HUMAN IGG1 IN MANY NUDE AND NU + MOUSE STRAINS IS DUE TO LOW IGG2A SERUM CONCENTRATIONS/, Cancer immunology and immunotherapy, 46(1), 1998, pp. 25-33
Authors:
BEHR TM
JENNER N
RADETZKY S
BEHE M
GRATZ S
YUCEKENT S
RAUE F
BECKER W
Citation: Tm. Behr et al., TARGETING OF CHOLECYSTOKININ-B GASTRIN RECEPTORS IN-VIVO - PRECLINICAL AND INITIAL CLINICAL-EVALUATION OF THE DIAGNOSTIC AND THERAPEUTIC POTENTIAL OF RADIOLABELED GASTRIN/, European journal of nuclear medicine, 25(4), 1998, pp. 424-430
Authors:
BEHR TM
GOLDENBERG DM
BECKER W
Citation: Tm. Behr et al., REDUCING THE RENAL UPTAKE OF RADIOLABELED ANTIBODY FRAGMENTS AND PEPTIDES FOR DIAGNOSIS AND THERAPY - PRESENT STATUS, FUTURE-PROSPECTS AND LIMITATIONS, European journal of nuclear medicine, 25(2), 1998, pp. 201-212
Authors:
RIEDMAYR MI
TAMMEN AR
BEHR TM
WITTIG C
BULLINGER M
REICHART B
ANGERMANN CE
Citation: Mi. Riedmayr et al., PERSPECTIVES OF PATIENTS WITH TERMINAL HEART-FAILURE - QUALITY-OF-LIFE AND WELL-BEING BEFORE AND IN THE FIRST-YEAR AFTER HEART-TRANSPLANTATION, Zeitschrift fur Kardiologie, 87(10), 1998, pp. 808-816
Authors:
BEHR TM
LIERSCH T
GRATZ S
SCHMIDT F
CANELO R
LORF T
POST S
WORMANN B
HIDDEMANN W
BECKER H
RINGE B
BECKER W
Citation: Tm. Behr et al., RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER PATIENTS WITH SMALL-VOLUME DISEASE - RESULTS OF AN ONGOING PHASE-I II TRIAL/, The Journal of nuclear medicine, 39(5), 1998, pp. 269-269
Authors:
BEHR TM
MEMTSOUDIS S
SHARKEY RM
BLUMENTHAL RD
DUNN RM
GOLDENBERG DM
BECKER W
Citation: Tm. Behr et al., ANTIBODY FRAGMENTS IN RADIOIMMUNOTHERAPY (RIT) - THE ROLE OF THE RADIATION-DOSE AND DOSE-RATE ON TOXICITY AND ANTITUMOR EFFICACY, The Journal of nuclear medicine, 39(5), 1998, pp. 439-439
Authors:
BEHR TM
GRATZ S
CONRAD M
MELLER J
HANSEN HJ
GOLDENBERG C
GOLDENBERG DM
BECKER W
Citation: Tm. Behr et al., INTRAINDIVIDUAL COMPARISON OF COMPLETE IGG VERSUS FAB' FRAGMENTS OF THE ANTI-NCA-90 ANTIBODY, MN-3, FOR BONE-MARROW SCINTIGRAPHY, The Journal of nuclear medicine, 39(5), 1998, pp. 442-442
Authors:
BEHR TM
HOTTE P
WEBER E
YUCEKENT S
GRATZ S
CONRAD M
MELLER J
HUFNER M
BECKER W
Citation: Tm. Behr et al., RADIATION ABSORBED DOSES AND THEIR BIOLOGICAL EFFECTS IN THE RADIOIODINE THERAPY OF DIFFERENTIATED THYROID-CANCER - A REINVESTIGATION OF FACTORS THAT INFLUENCE THE DOSIMETRY AND THE THERAPEUTIC OUTCOME, The Journal of nuclear medicine, 39(5), 1998, pp. 851-851
Authors:
BEHR TM
KRUCK E
HOMAYOUNFAR T
GRATZ S
CONRAD M
MELLER J
SCHREIVOGEL I
BECKER W
Citation: Tm. Behr et al., DETECTION OF RECURRENT OR METASTATIC THYROID-CANCER BY RAPID CHROMATOGRAPHIC ANALYSIS OF THE PATIENTS ABILITY TO ENDOGENOUSLY SYNTHESIZE THYROID-HORMONES FROM ORALLY-ADMINISTERED RADIOIODINE, The Journal of nuclear medicine, 39(5), 1998, pp. 1151-1151
Authors:
BEHR TM
RICHTER K
FISCHER P
SPES CH
MEISER B
REICHART B
PONGRATZ D
FEUCHT H
THEISEN K
ANGERMANN CE
Citation: Tm. Behr et al., INCIDENCE OF HUMORAL REJECTION IN HEART-TRANSPLANT RECIPIENTS TREATEDWITH TACROLIMUS OR CYCLOSPORINE-A, Transplantation proceedings, 30(5), 1998, pp. 1920-1921
Authors:
BEHR TM
MEMTSOUDIS S
SHARKEY RM
BLUMENTHAL RD
DUNN RM
GRATZ S
WIELAND E
NEBENDAHL K
SCHMIDBERGER H
GOLDENBERG DM
BECKER W
Citation: Tm. Behr et al., EXPERIMENTAL STUDIES ON THE ROLE OF ANTIBODY FRAGMENTS IN CANCER RADIO-IMMUNOTHERAPY - INFLUENCE OF RADIATION-DOSE AND DOSE-RATE ON TOXICITY AND ANTITUMOR EFFICACY, International journal of cancer, 77(5), 1998, pp. 787-795
Authors:
BEHR TM
SGOUROS G
VOUGIOUKAS V
MEMTSOUDIS S
GRATZ S
SCHMIDBERGER H
BLUMENTHAL RD
GOLDENBERG DM
BECKER W
Citation: Tm. Behr et al., THERAPEUTIC EFFICACY AND DOSE-LIMITING TOXICITY OF AUGER-ELECTRON VS.BETA-EMITTER IN RADIOIMMUNOTHERAPY WITH INTERNALIZING ANTIBODIES - EVALUATION OF I-125-LABELED VS I-131-LABELED CO17-1A IN A HUMAN COLORECTAL-CANCER MODEL, International journal of cancer, 76(5), 1998, pp. 738-748
Authors:
BEHR TM
BECKER W
GOLDENBERG DM
SCHEELE JR
WOLF FG
Citation: Tm. Behr et al., CLINICAL RELEVANCE OF IMMUNOSCINTIGRAPHY WITH TC-99M-LABELED ANTI-CEAANTIGEN-BINDING FRAGMENTS IN THE FOLLOW-UP OF PATIENTS WITH COLORECTAL-CARCINOMA - ASSESSMENT OF RESECTABILITY BY A COMBINATION OF CONVENTIONAL IMAGING METHODS, Deutsche Medizinische Wochenschrift, 122(15), 1997, pp. 463-470
Authors:
SHARKEY RM
KARACAY H
GRIFFITHS GL
BEHR TM
BLUMENTHAL RD
MATTES MJ
HANSEN HJ
GOLDENBERG DM
Citation: Rm. Sharkey et al., DEVELOPMENT OF A STREPTAVIDIN-ANTI-CARCINOEMBRYONIC ANTIGEN-ANTIBODY,RADIOLABELED BIOTIN PRETARGETING METHOD FOR RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER - STUDIES IN A HUMAN COLON-CANCER XENOGRAFT MODEL, Bioconjugate chemistry, 8(4), 1997, pp. 595-604
Authors:
BECKER W
BEHR TM
KLEIN M
SCHEELE JR
WOLF FG
GOLDENBERG DM
Citation: W. Becker et al., CLINICAL IMPACT OF IMMUNOSCINTIGRAPHY WITH TC-99M-LABELED ANTI-CEA FAB IN THE FOLLOW-UP OF COLORECTAL-CANCER PATIENTS - PREDICTION OF SURGICAL RESECTABILITY FROM THE COMBINATION WITH CT, European journal of cancer, 33, 1997, pp. 718-718
Authors:
BEHR TM
JUWEID ME
SHARKEY RM
HOLLER E
DUNN RM
KOLB HJ
WORMANN B
HIDDEMANN W
GOLDENBERG DM
BECKER W
Citation: Tm. Behr et al., CD22 AS TARGET FOR RADIOIMMUNOTHERAPY OF HEMATOLOGICAL MALIGNANCIES OF B-CELL ORIGIN (NON-HODGKINS-LYMPHOMA, ACUTE LYMPHATIC-LEUKEMIA AND MACROGLOBULINEMIA), European journal of cancer, 33, 1997, pp. 1187-1187
Authors:
SHARKEY RM
BEHR TM
MATTES MJ
STEIN R
GRIFFITHS GL
SHIH LB
HANSEN HJ
BLUMENTHAL RD
DUNN RM
JUWEID ME
GOLDENBERG DM
Citation: Rm. Sharkey et al., ADVANTAGE OF RESIDUALIZING RADIOLABELS FOR AN INTERNALIZING ANTIBODY AGAINST THE B-CELL LYMPHOMA ANTIGEN, CD22, Cancer immunology and immunotherapy, 44(3), 1997, pp. 179-188
Authors:
BEHR TM
GRATZ S
MARKUS PM
DUNN RM
HUFNER M
BECKER H
BECKER W
Citation: Tm. Behr et al., ENHANCED BILATERAL SOMATOSTATIN RECEPTOR EXPRESSION IN MEDIASTINAL LYMPH-NODES (CHIMNEY SIGN) IN OCCULT METASTATIC MEDULLARY-THYROID CANCER- A TYPICAL SITE OF TUMOR MANIFESTATION, European journal of nuclear medicine, 24(2), 1997, pp. 184-191
Authors:
BEHR TM
GOLDENBERG DM
BECKER WS
Citation: Tm. Behr et al., RADIOIMMUNOTHERAPY OF SOLID TUMORS - A REVIEW OF MICE AND MEN, Hybridoma, 16(1), 1997, pp. 101-107
Authors:
BEHR TM
FISCHER P
MUDRA H
THEISEN K
SPES C
UBERFUHR P
MULLERFELBER W
PONGRATZ DE
ANGERMANN C
Citation: Tm. Behr et al., UP-REGULATION OF UTROPHIN IN THE MYOCARDIUM OF A CARRIER OF DUCHENNE MUSCULAR-DYSTROPHY, European heart journal, 18(4), 1997, pp. 699-700
Authors:
BEHR TM
SHARKEY RM
JUWEID ME
DUNN RM
VAGG RC
YING ZL
ZHANG CH
SWAYNE LC
VARDI Y
SIEGEL JA
GOLDENBERG DM
Citation: Tm. Behr et al., PHASE I II CLINICAL RADIOIMMUNOTHERAPY WITH AN IODINE-131-LABELED ANTICARCINOEMBRYONIC ANTIGEN MURINE MONOCLONAL-ANTIBODY IGG/, The Journal of nuclear medicine, 38(6), 1997, pp. 858-870
Authors:
BEHR TM
MEMTSOUDIS S
BLUMENTHAL RD
DUNN RM
NEBENDAHL K
SHARKEY RM
GOLDENBERG DM
BECKER W
Citation: Tm. Behr et al., RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER IN MINIMAL RESIDUAL DISEASE AND IN AN ADJUVANT SETTING - EVALUATION OF I-131-LABELED AND Y-90-LABELED IGG AND FRAGMENTS VERSUS STANDARD CHEMOTHERAPY IN A NUDE-MOUSE MODEL, The Journal of nuclear medicine, 38(5), 1997, pp. 14-14